Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tate & Lyle plc (TATYF)
London, GB
Tate & Lyle PLC, a company established in London in 1903, operates globally, providing a comprehensive range of ingredients and specialized solutions through its subsidiaries to the food, beverage, and other industrial sectors, spanning the United States, the United Kingdom, various European nations, and beyond. The business is structured into three key divisions: Food & Beverage Solutions, Sucralose, and Primary Products. Its product portfolio encompasses texturants, nutritive sweeteners like high-fructose corn syrup and dextrose, health and wellness compounds, and stabilizers. Furthermore, it supplies industrial starches for applications in paper, packaging, and adhesives, alongside acidulants such as citric acid. Commodity offerings include corn gluten feed and meal for animal nutrition, corn oil, and ethanol. Beyond these core product lines, the company also engages in treasury and insurance activities and offers research and development services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -1.70% | +44.17% | +26.05% | +38.96% | +35.95% | -7.49% | -30.80% | -48.44% | -31.21% | +25.82% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Packaged Foods: +4.4%+15.9% ★ Q1'26: +24.6% (vs Q1'24)
-
EPS growth Packaged Foods: +14.6%-37.1% Q1'26: -56.7% (vs Q1'24)
-
FCF margin FCF growth · Packaged Foods: +15.9%+5.1% ★ Q1'26: +5.3% (vs Q1'24)
-
EBIT margin Packaged Foods: +7.9%+9.0% ★ Q1'26: +8.4% (vs Q1'24)
-
ROIC Packaged Foods: +7.0%+5.3% Q1'26: +9.3% (vs Q1'24)
-
Share dilution Packaged Foods: +0.0%+7.7% Q1'26: +10.9% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×3.68× Q1'26: 1.97× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 11 Rev. Ana. 1 EPS Ana. |
Mar 2027 6 Rev. Ana. 1 EPS Ana. |
Mar 2028 11 Rev. Ana. 1 EPS Ana. |
Mar 2029 6 Rev. Ana. 1 EPS Ana. |
Mar 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.36B
est: 3.93B (-40.0%)
|
2.36B
est: 3.41B (-30.9%)
|
2.75B
est: 3.36B (-18.1%)
|
2.71B
est: 3.86B (-29.8%)
|
2.76B
est: 3.60B (-23.5%)
|
2.88B
est: 3.53B (-18.2%)
|
2.81B
est: 3.87B (-27.5%)
|
1.38B
est: 1.80B (-23.5%)
|
1.75B
est: 2.18B (-19.7%)
|
1.65B
est: 1.70B (-2.9%)
|
1.74B
est: 1.75B (-1.1%)
|
2.02B
1.96B – 2.05B
+14.9% YoY
|
2.06B
2.05B – 2.08B
+2.4% YoY
|
2.13B
2.06B – 2.22B
+3.3% YoY
|
2.20B
2.15B – 2.25B
+3.2% YoY
|
2.31B
2.26B – 2.36B
+4.8% YoY
|
| EBITDA |
276.00M
est: 570.88M (-51.7%)
|
286.00M
est: 495.74M (-42.3%)
|
399.00M
est: 488.85M (-18.4%)
|
436.00M
est: 561.31M (-22.3%)
|
423.00M
est: 523.22M (-19.2%)
|
468.00M
est: 512.39M (-8.7%)
|
292.00M
est: 562.61M (-48.1%)
|
148.00M
est: 261.33M (-43.4%)
|
279.00M
est: 316.79M (-11.9%)
|
345.00M
est: 246.62M (+39.9%)
|
254.00M
est: 280.12M (-9.3%)
|
321.98M
313.63M – 327.13M
+14.9% YoY
|
329.56M
327.33M – 331.52M
+2.4% YoY
|
340.36M
328.13M – 354.78M
+3.3% YoY
|
351.21M
343.62M – 359.81M
+3.2% YoY
|
368.09M
360.13M – 377.10M
+4.8% YoY
|
| EBIT |
57.00M
est: 352.67M (-83.8%)
|
155.00M
est: 306.25M (-49.4%)
|
266.00M
est: 301.99M (-11.9%)
|
319.00M
est: 346.76M (-8.0%)
|
271.00M
est: 323.23M (-16.2%)
|
329.00M
est: 316.54M (+3.9%)
|
117.00M
est: 347.56M (-66.3%)
|
68.00M
est: 161.44M (-57.9%)
|
184.00M
est: 195.71M (-6.0%)
|
251.00M
est: 152.35M (+64.8%)
|
126.00M
est: 164.67M (-23.5%)
|
189.28M
184.37M – 192.30M
+14.9% YoY
|
193.74M
192.42M – 194.89M
+2.4% YoY
|
200.08M
192.89M – 208.56M
+3.3% YoY
|
206.46M
202.00M – 211.52M
+3.2% YoY
|
216.38M
211.71M – 221.68M
+4.8% YoY
|
| Net Income |
30.00M
est: 226.26M (-86.7%)
|
163.00M
est: 202.12M (-19.4%)
|
256.00M
est: 247.96M (+3.2%)
|
265.00M
est: 286.16M (-7.4%)
|
181.00M
est: 276.59M (-34.6%)
|
245.00M
est: 282.71M (-13.3%)
|
253.00M
est: 349.98M (-27.7%)
|
236.00M
est: 255.21M (-7.5%)
|
190.00M
est: 245.79M (-22.7%)
|
188.00M
est: 224.81M (-16.4%)
|
143.00M
est: 217.03M (-34.1%)
|
180.73M
175.65M – 186.48M
-16.7% YoY
|
179.98M
174.92M – 185.70M
-0.4% YoY
|
202.39M
196.71M – 208.83M
+12.5% YoY
|
223.76M
217.47M – 230.88M
+10.6% YoY
|
267.06M
259.56M – 275.56M
+19.4% YoY
|
| SGA |
478.00M
est: 331.38M (+44.2%)
|
480.00M
est: 287.76M (+66.8%)
|
496.00M
est: 283.76M (+74.8%)
|
2.42B
est: 325.82M (+642.7%)
|
570.00M
est: 303.71M (+87.7%)
|
541.00M
est: 297.43M (+81.9%)
|
104.00M
est: 326.58M (-68.2%)
|
132.00M
est: 151.69M (-13.0%)
|
224.00M
est: 183.89M (+21.8%)
|
265.00M
est: 143.15M (+85.1%)
|
—
est: 135.04M (-100.0%)
|
155.23M
151.20M – 157.71M
+14.9% YoY
|
158.88M
157.81M – 159.83M
+2.4% YoY
|
164.09M
158.19M – 171.04M
+3.3% YoY
|
169.32M
165.66M – 173.46M
+3.2% YoY
|
177.46M
173.62M – 181.80M
+4.8% YoY
|
| EPS |
0.08
est: 0.54 (-85.9%)
|
0.41
est: 0.49 (-15.8%)
|
0.64
est: 0.60 (+7.2%)
|
0.67
est: 0.69 (-2.8%)
|
0.46
est: 0.67 (-30.9%)
|
0.62
est: 0.68 (-8.9%)
|
0.64
est: 0.84 (-24.1%)
|
0.59
est: 0.61 (-4.0%)
|
0.47
est: 0.59 (-20.6%)
|
0.44
est: 0.54 (-18.7%)
|
0.35
est: 0.49 (-27.9%)
|
0.40
0.39 – 0.42
-16.7% YoY
|
0.40
0.39 – 0.42
-0.4% YoY
|
0.45
0.44 – 0.47
+12.5% YoY
|
0.50
0.49 – 0.52
+10.6% YoY
|
0.60
0.58 – 0.62
+19.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B- | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 2/5 | 2/5 | 3/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anthony Nicholas Seymour Hampton | Chief Executive Officer & Executive Director | 2M | male |
| Sarah Mary Kuijlaars | Chief Financial Officer & Director | 928.5K | female |
| Didier Viala | President of Americas | — | male |
| Jan-Jaap Van Der Bij | Senior Vice President of Global Environment, Health, Safety, Quality & Security | — | — |
| Kavita Karnik | Global Head of Nutrition, Regulatory & Scientific Affairs | — | — |
| Lauren Higgins | Head of Ethics and Compliance | — | female |
| Lindsay Beardsell | General Counsel | — | female |
| Melissa | Chief Commercial & Transformation Officer | — | female |
| Rowan Adams | Chief Corporate Affairs & Sustainability Officer | — | male |
| Tamsin Vine | Chief People Officer | — | female |
| Victoria Spadaro Grant | Chief Science & Innovation Officer | — | female |
| Christopher Marsh | Vice President of Investor Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TATYF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
